PP
AGN.PRA

Prudential plc’s Allergan plc AGN.PRA Stock Holding History

Prudential plc’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-39,730
Closed -$23.3M – 780
2017
Q4 		$23.3M Hold
39,730
– – 0.07% 244
2017
Q3 		$29.3M Hold
39,730
– – 0.09% 208
2017
Q2 		$34.5M Hold
39,730
– – 0.11% 194
2017
Q1 		$33.8M Hold
39,730
– – 0.11% 198
2016
Q4 		$30.3M Sell
39,730
-13,000
-25% -$9.82M 0.11% 197
2016
Q3 		$43.3M Hold
52,730
– – 0.16% 149
2016
Q2 		$44M Sell
52,730
-4,363
-8% -$3.64M 0.17% 149
2016
Q1 		$52.5M Buy
57,093
+3,593
+7% +$3.44M 0.21% 129
2015
Q4 		$55.1M Buy
53,500
+2,534
+5% +$2.55M 0.22% 121
2015
Q3 		$48.1M Buy
50,966
+1,489
+3% +$1.55M 0.21% 125
2015
Q2 		$51.6M Buy
+49,477
New +$51.8M 0.2% 126

Other funds holding AGN.PRA

PWS
Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Prudential plc's AGN.PRA Position: Q1 2018 in Review

Prudential plc sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 39,730 shares — an estimated $23.3M sold.

Prudential plc first reported a position in AGN.PRA in Q2 2015 and held it in 11 quarters. The position peaked at $55.1M in Q4 2015. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • Prudential plc reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Prudential plc sold 39,730 Allergan plc shares in Q1 2018, an estimated $23.3M.
  • Prudential plc first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
  • Prudential plc's Allergan plc position peaked at $55.1M in Q4 2015.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Prudential plc's 13F filing for Q1 2018, filed 15 May 2018.